Bosetti, Francesca

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 603

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease

Bosetti, F. (2002) · Neurobiology of Aging

Mitochondrial Function and PathologyAlzheimer's disease research and treatments

Cited by 348

The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline

Corriveau, R. A., Bosetti, F., Emr, M., Gladman, J. T., Koenig, J. I., Moy, C. S., Pahigiannis, K., Waddy, S. P., & Koroshetz, W. (2016) · Cellular and Molecular Neurobiology

Neurological Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 240

Translational Stroke Research: Vision and Opportunities

Bosetti, F., Koenig, J. I., Ayata, C., Back, S. A., Becker, K., Broderick, J. P., Carmichael, S. T., Cho, S., Cipolla, M. J., Corbett, D., et al. (2017) · Stroke

Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage Research

Cited by 171

Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain

Ghelardoni, S., Tomita, Y. A., Bell, J. M., Rapoport, S. I., & Bosetti, F. (2004) · Biological Psychiatry

Bipolar Disorder and TreatmentInflammatory mediators and NSAID effects

Cited by 95

The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results

Lyden, P. D., Bosetti, F., Diniz, M. A., Rogatko, A., Koenig, J. I., Lamb, J., Nagarkatti, K. A., Cabeen, R. P., Hess, D. C., Kamat, P. K., et al. (2022) · Stroke

Acute Ischemic Stroke ManagementAnimal testing and alternatives

Cited by 73

The cyclooxygenase‐2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone‐induced demyelination

Palumbo, S., Toscano, C. D., Parente, L., Weigert, R., & Bosetti, F. (2012) · Journal of Neurochemistry

Multiple Sclerosis Research StudiesInflammatory mediators and NSAID effects

Cited by 46

Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination

Palumbo, S., Toscano, C. D., Parente, L., Weigert, R., & Bosetti, F. (2011) · Prostaglandins, Leukotrienes and Essential Fatty Acids

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 33